Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: Week 104 results from the SUNSHINE and SUNRISE extension trial
- Alexa B Kimball*
- , Falk G Bechara
- , Aysha Badat
- , Evangelos J Giamarellos-Bourboulis
- , Alice B Gottlieb
- , Gregor B E Jemec
- , Ziad Reguiai
- , Axel P Villani
- , Ivette Alarcon
- , Amita Bansal
- , Francesca Gasperoni
- , Ruvie Martin
- , Bertrand Paguet
- , Lorenz Uhlmann
- , Hichem Zouater
- , Shoba Ravichandran
- , Afsaneh Alavi
*Corresponding author for this work
Research output: Contribution to journal › Article › Research › peer-review